About Immunomet Therapeutics
Immunomet Therapeutics is a private company based in Houston, Texas. It has reported $842,211 raised in one offering on Form D since February 2026. Its chief executive is Dean Welsch.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 21, 2026 | Feb 5, 2026 | $842,211of $10.0M target | 4 | $210K | Equity, OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Immunomet Therapeutics's Form D filed Feb 5, 2026.
DW
Dean Welsch
Chief Executive Officer and director